Fenofibrate for hypertriglyceridemia
Medical Letter on Drugs and Therapeutics 40(1030): 68-69
1998
ISSN/ISBN: 0025-732X PMID: 9664930 Document Number: 492905
Document emailed within 1 workday
Related Documents
Harvengt, C.; Desager, J.P. 1980: Pharmacokinetics of fenofibrate in man La Nouvelle Presse Medicale 9(49): 3725-3727Leroy, D.; Dompmartin, A.; Lorier, E.; Leport, Y.; Audebert, C. 1990: Photosensitivity induced by fenofibrate Photodermatology Photoimmunology and Photomedicine 7(3): 136-137
Martínez Triguero, M.L. 1993: Literature review on fenofibrate Anales de Medicina Interna 10(4): 195-199
Sucić, M. 1989: The effect of fenofibrate in various types of hyperlipoproteinemias Lijecnicki Vjesnik 111(3): 93-97
Giraud, P.; Cassou, M.; Paul, R.; Guidet, M. 1982: Muscular toxicity due to fenofibrate. Apropos of a case Revuedu Rhumatisme et des Maladies Osteo-Articulaires 49(2): 162
Bravo, M.L.; Azagra, R.; Aguyé, A.; Freixas, M. 1992: Acute hepatitis: an adverse reaction to fenofibrate treatment Atencion Primaria 10(3): 697-698
Pichon, N.; Vincensini, J.-F.ço.; Rozière, A.; Labrousse, F.ço.; Sautereau, D.; Pillegand, B. 2003: Acute cytolytic and cholestatic hepatitis induced by fenofibrate Gastroenterologie Clinique et Biologique 27(10): 947-949
Kalra, S.; Sahay, R. 2018: Improving Diabetic Retinopathy Outcomes: FIELD Fenofibrate Journal of the Association of Physicians of India 66(12): 55-57
Häring, H.U.; Schleicher, E.; Renner, R.; Mehnert, H. 1983: The effect of fenofibrate on the lipid level in diabetic patients Münchener Medizinische Wochenschrift 125(35): 751-753
Micheli, H.; Pometta, D.; Gustafson, A. 1980: Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins a and B in type IIa HLP La Nouvelle Presse Medicale 9(49): 3759-3762
Fricker, J.; Douste-Blazy, P.; Drouin, P.; De Gennes, J.L.; Dachet, C.; Keller, U. 1990: The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia Presse Medicale 19(42): 1927-1930
Rouhier, M.L.; Rifflet, H.; Rifflet, I.; Oberti, F.; Vuillemin, E.; Chevailler, A.; Calès, P. 1996: Painful acute liver involvement related to ingestion of fenofibrate Gastroenterologie Clinique et Biologique 20(12): 1137-1138
Duda-Król, W.; Jórasz, I.; Dabrowska, M.; Polubiec, A.; Kusz-Rynkun, A. 2000: Septic-toxic shock due to rhabdomyolysis in a patient treated with fenofibrate Wiadomosci Lekarskie 53(7-8): 454-457
Turki, S.; Mekaouer, A.; Kaabachi, A.; Ftouhi, B.; Mebazaa, R.; Ben Khalifa, F. 1994: Therapeutic trial of simvastatin versus fenofibrate in primary hypercholesterolemia La Tunisie Medicale 72(11): 619-624
Okopień, B.ła.; Cwalina, Łu.; Haberka, M.; Kowalski, J.; Zieliński, M.; Szwed, Z.; Kalina, Z.; Herman, Z.S. 2002: Pleiotropic effects of micronized fenofibrate in patients with combined hyperlipidemia Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(78): 465-469
Schwartzkopff, W.; Luley, C.; Scheffler, W.; Lehmann-Leo, W.; Schilling, A.; Wegscheider, K. 1982: Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV Die Medizinische Welt 33(17): 631-637
Kotake, H.; Oikawa, S. 2001: Idiopathic hypertriglyceridemia Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 79-87
Nagao, M.; Oikawa, S. 2007: Intervention for hypertriglyceridemia Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 257-263
Turpin, G.; Bruckert, E. 1994: Iatrogenic hypertriglyceridemia Presse Medicale 23(24): 1132-1135
Reaven, G.M.; Javorski, W.C.; Reaven, E. 1975: Diabetic hypertriglyceridemia American Journal of the Medical Sciences 269(3): 382-389